Navigation Links
eDiets.com(R) Announces Q2 2008 Results
Date:8/6/2008

FORT LAUDERDALE, Fla., Aug. 6 /PRNewswire-FirstCall/ -- eDiets.com, Inc. (Nasdaq: DIET), leveraging the power of the Internet to bring diet, fitness and healthy lifestyle solutions to everyone, today announced results for the second quarter and six months ended June 30, 2008.

Revenues for the second quarter of 2008 were $6.5 million, compared to $7.6 million in the prior year period. Net loss for the quarter was $(3.1) million, or $(0.12) per diluted share, for the second quarter of 2008, compared to $(1.4) million, or $(0.06) per diluted share, for the second quarter of 2007.

Adjusted EBITDA*, defined as net income (loss) before interest, taxes, depreciation, amortization, stock-based compensation, severance charges, bad debt expense and loss on disposition of assets, for the quarter ended June 30, 2008 was $(1.4) million compared to ($0.4) million in the prior year period.

For the six months ended June 30, 2008, the Company recorded revenues of $15.2 million compared $16.0 million for the same period last year. Net loss was $(8.3) million, or $(0.33) per share, compared to $(2.7) million, or $(0.11) per share, for the first six months of 2007. Adjusted EBITDA for the first half of 2008 totaled $(4.8) million compared to $(0.9) million in the comparable year period.

Second Quarter 2008 and Subsequent Highlights:

-- Achieved over 280% increase in Q2 2008 meal delivery revenues from

prior year

-- Signed and launched co-branded meal delivery program with national

health and wellness expert Jillian Michaels of NBC's The Biggest Loser

-- Signed 8 B2B contracts and launched 5 B2B programs year-to-date

-- Signed new agreement with food supplier significantly improving<
'/>"/>

SOURCE eDiets.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
2. eDiets.com(R) Announces Q4 and Year End 2007 Results
3. eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008
4. eDiets.com(R) Announces Q1 2008 Results
5. eDiets.com(R) Appoints New Chief Information Officer Laura Klein
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... promotes self-assurance, research finds , ...r may have been right when she told you to sit up ...could make you feel more confident about your thou...p straight gives a good impression to other people...chology professor at Ohio State University, said i...
(Date:11/8/2009)...ire-USNewswire/ -- Speaker Nancy Pelosi and Democr... House passage of H.R. 3962, the Affordable Health...of 220 to 215. Below are the Speaker,s opening re...ceived a call from the President of the United Sta...ctory for the American people. I thank the Preside...
(Date:11/8/2009)...drying of biopharmaceuticals to be available at th... , Toronto, ON (PRWEB) Nov... of Therapure Biopharma Inc. today announced that ...le pharmaceutical grade freeze dryer and expects t...ion) available for contract manufacturing of bioph...
(Date:11/8/2009)... the battle is won," said Dr. Charmaine Yoest. ,...In a vote of 240-194, the Stupak-Ellsworth-Pitts-K...bit abortion mandates and funding in HR 3962 passe...ife Action President and CEO Dr. Charmaine Yoest s...or the pro-life Americans across this country who ...
(Date:11/8/2009)... H.R. 3961 to Secure the Stability of Medicare ,...tement Attributable to: J. James Rohack, M.D., Pre... http://www.newscom.com/cgi-bin/prnh/20081209/AM...House health reform bill, which will help improve ...calls for swift passage of H.R. 3961 to secure the...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...ame of a Class 10 correspondence course student in...iled to do, an official said Saturday//. The ...d 22 students of various private and government hi...at had three others with the same score. The boy h...
...sights about how a bacterium uses different recept...a are sensitive to minute changes in environments ...of 1 drop in a pool of 1,000 drops. New Corn...perative lattice on a bacterium's surface to ampli...
... essential for proper embryo development and disor...h defects such as cleft palate, spina bifida, repo...ffort of the University of Colorado, Health Scienc...Critical for Downregulation of E-Cadherin During M...
...announced a warning on the usage of Triaminic vapo...serious effects //they could have if accidentally ...h authorities have explained that life-threatening...ised as a cough suppressant for kids 2 years of ag...
...fter eating (traditionally called European siesta)... happening due to changes in glucose levels//. ...y in humans and as well as in animals become switc...sed from the neurons, whose action is focused on t...
...er treatment drug has proved so well in the drug t...ght be made //available to patients in the late st...the regulators. It is speculated that Europe... claim that unlike Roche's $1.8bn-a-year drug, Her...
Other Medicine News:Health News:Study Highlights How Bacteria Respond To Changes In Environment 2Health News:GSK’s New Anticancer Drug A Huge Success In Drug trail 2
(Date:11/6/2009)...TA, Nov. 6 GeoVax Labs,...e Company"), an Atlanta-based, biopharmaceutical c...ed by HIV-1 (Human Immunodeficiency Virus) and oth...arter 2009 financial results and provided an opera...ent and Chief Executive Officer commented, "We are...
(Date:11/6/2009)...IEGO, Nov. 6 California American W...s "No Drugs Down the Drain" week for its San Diego...n sponsored by public and private agencies alike t...l pollution in our source water supplies. ,, Ca...rs are encouraged to drop off expired or unwanted ...
(Date:11/5/2009)...IEGO, Nov. 5 Althea Technologies,...acturing services for biopharmaceutical products a...velopment to the company,s platform of services, w...ames Matsuura, Director of Formulation Development...ation and analytical scientists, along with new la...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29 2009 5323 1Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29 2009 5323 2Hutchinson Center scientists net 2416 7 million for stem cell research 59136 1Hutchinson Center scientists net 2416 7 million for stem cell research 59136 2Elderly immune system needs a boost 59134 1Elderly immune system needs a boost 59134 2
... 12 Boston,Scientific Corporation (NYSE: BSX ) t...7,500 patients from its TAXUS ARRIVE 1 and 2 regis...ce of the TAXUS(R) Express2(TM),Paclitaxel-Eluting...,two-year pooled ARRIVE data showed that the TAXUS...h diabetes as effectively as in patients without,d...
...entific,Corporation (NYSE: BSX ) today announced ...ss announcements at the Cardiovascular Research Fo...rdiovascular Therapeutics (TCT),scientific symposi..., D.C., Boston Scientific will be announcing a wi...R) Express2(TM) and second-generation TAXUS(R),Lib...
Other Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
... disease ELISA products make us a leader in this f...egration into the busy laboratory, our Infectious ...ty and run-to-run consistency. Our Infectious Dise...for a wide range of serological assays including T...
Giardia lamblia II EIA
Medicine Products: